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1. INTRODUCTION 
Disease always co-existed with livings, detecting their remedies also always 
continuing, going through the commencement of drug therapy for disease, drugs comes to 
the force in sudden, in the ancient time human knowledge found the absence of some 
food forms the base for the development of some disease, they were tried to use the same 
food material for curing that particular disease and they got success in that work. This 
motivates the plant researchers to use different plants, plant parts for different ailments. 
In olden days they used plants as such and then made into different formulations 
for their expediency such as powder, juice, decoction, extracts etc. Our traditional system 
of medicine siddha categorized nearly 5000 plant species and their usage. Later on the 
allopathic system of medicine comes to force and dominate the siddha and due to the fast 
relieving nature it reached the world as quickly and diminished the usage of plant 
medicine as maximum. But allopathic system cannot provide ultimate solution to some 
disease and also their side effect in particularly the long term therapy, limits their usage 
still the plant medicine is recommended and used in such cases. This suggests the plant 
medicine to researchers as and scientific world as alternate to allopathic system of 
medicine. The world health organization recognize and motivate the plant researchers, 
hence the plant medicine now considered being an alternative system of medicine. 
Even usage of plants are known, since plant species consists of mixture of 
compound, isolating the single compound and identifying the component is responsible 
for that particular activity is a major question in front of plant researcher and also it is 
very difficult to say only these are all the compounds available from particular plant. 
Nowadays due to the development of science and technology such as 
chromatographic technique and spectroscopic technique it is possible to isolate almost all 
the components of plant and characterize them. Isolation and characterization are very 
important to improve the effectiveness, minimizing the dose and on set of action. 
Now this study is considered as a separate discipline called “photochemistry” 
defined as a branch of science somewhere in between natural product organic chemistry 
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and plant biochemistry concerned with organic substances accumulated by plants and 
deals with the chemical structure of these substances, their biosynthesis, turnover, 
metabolism, their natural distribution and their biological function. Since detecting the 
compound responsible for the particular activity, isolating, characterizing the compound 
and monitoring the activity is of prime importance, the basic requirement needed for the 
medicinal world, it is the duty of the chemist to do this works.1 
HERBAL MEDICINES 
Medicinal plants are the oldest known health care source. Their importance is 
still growing although it varies depending on the ethnological, medical and historical 
background of each country. Medicinal plants are also importance for pharmacological 
research and drug development, not only when plant constituents are used directly as 
basic materials for the synthesis of drugs or as models for pharmacologically active 
compounds. 
The World Health Organization (WHO) estimates that billion people, 80 percent 
of the world population, presently use herbal medicine for one or the other aspect of 
primary health care. Herbal medicine is a major component in all people’s indigenous 
traditional medicine and a common element in Ayurvedic, Homeopathic, Naturopathic, 
Traditional oriental and Native American Indian Medicine. Plants have provided the 
lead molecules for a large number of diseases. During the past 40 years numerous novel 
compounds have been isolated from plant sources and many of this substance have been 
demonstrated to possess interesting biological activities. 
APPROACHES TO NATURAL PRODUCT RESEARCH AND DRUG 
DISCOVERY 
Different approaches to drug discovery from plants can be enumerated as: random 
selection followed by chemical screening, random selection followed by one or more 
biological assays, follow-up of biological activity reports, follow-up of ethno-medical 
(traditional medicine) use of plants, use of appropriate plant parts as such in powdered 
form or preparation of enriched/standardized extracts (herbal product development), use 
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of a plant product, biologically potent but beset with other issues, as a lead for further 
chemistry, and single new compounds as drugs. The objective of the later approach is the 
targeted isolation of new bioactive plant products, i.e. lead substances with novel 
structures and novel mechanisms of action. This approach has provided a few classical 
examples, but the problem most often encountered here is not enough availability. The 
problem of availability can be overcome by semi synthesis/ synthesis or using tissue-
culture techniques (by genetically modifying the biosynthetic pathway of the compound 
of interest). 
OLDER APPROACH 
• Focused on chemistry of compounds from natural sources, but not on activity. 
• Straightforward isolation and identification of compounds from natural sources 
followed by testing of biological activity in animal model. 
• Chemotaxonomic investigation. 
• Selection of organisms primarily based on ethno pharmacological information, 
folkloric reputations, or traditional uses. 
MODERN APPROACH 
• Bioassay-directed (mainly in vitro) isolation and identification of active lead 
compounds from natural sources. 
• Production of natural products libraries. 
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Figure 1: Steps involved in drug discovery from plants 
• Production of active compounds by cell or tissue culture, genetic manipulation, 
natural combinatorial chemistry and so on. 
• More focused on bioactivity. 
• Introduction of the concepts of de-replication, chemical fingerprinting, and 
metabolomics. 
• Selection of organisms based on ethno pharmacological information, folkloric 
reputations, or traditional uses, and also those randomly selected.2 
CHALLENGES IN DRUG DISCOVERY FROM MEDICINAL PLANTS 
In spite of the success of drug discovery programs from plants in the past 2-3 
decades, future endeavors face many challenges. Natural products scientists and 
pharmaceutical industries will need to continuously improve the quality and quantity of 
compounds that enter the drug development phase to keep pace with other drug discovery 
efforts. The process of drug discovery has been estimated to take an average period of 10 
years and cost more than 800 million dollars.3 It is estimated that only one in 5000 lead 
compounds will successfully advance through clinical trials and be approved for use. In 
the drug discovery process, lead identification is the first step. Lead optimization 
(involving medicinal and combinatorial chemistry), lead development (including 
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pharmacology, toxicology, pharmacokinetics, ADME and drug delivery), and clinical 
trials all take considerable time. 
As drug discovery from plants has traditionally been time-consuming, faster and 
better methodologies for plant collection, bioassay screening, compound isolation and 
compound development must be employed
.
 Innovative strategies to improve the process 
of plant collection are needed, especially with the legal and political issues surrounding 
benefit-sharing agreements.4
 
The design, determination and implementation of appropriate, clinically relevant, 
high throughput bioassays are difficult processes for all drug discovery programs. The 
common problem faced during screening of extracts is solubility and the screening of 
extract libraries is many times problematic, but new techniques including pre-
fractionation of extracts can alleviate some of these issues. Challenges in bioassay 
screening still remain an important issue in the future of drug discovery from medicinal 
plants. The speed of active compound isolation can be increased using hyphenated 
techniques like LC-NMR and LC-MS. Development of drugs from lead compounds 
isolated from plants, faces unique challenges. Natural products, in general, are typically 
isolated in small quantities that are insufficient for lead optimization, lead development 
and clinical trials. Thus, there is a need to develop collaborations with synthetic and 
medicinal chemists to explore the possibilities of its semi-synthesis or total synthesis.5
 
One can also improve the natural products compound development by creating natural 
products libraries that combine the features of natural products with combinatorial 
chemistry. 
OPPORTUNITIES IN DRUG DISCOVERY FROM MEDICINAL PLANTS 
Bio prospecting demands a number of requirements which should be co-
coordinated, such as team of scientific experts (from all the relevant interdisciplinary 
fields) along with expertise in a wide range of human endeavors, including international 
laws and legal understanding, social sciences, politics and anthropology. In our context, 
Ayurveda and other traditional systems of medicine, rich genetic resources and associated 
ethno medical knowledge are key components for sustainable bio prospecting and value-
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addition processes. 
For drug-targeted bio prospecting an industrial partner is needed, which will be 
instrumental in converting the discovery into a commercial product. Important in any bio 
prospecting is the drafting and signing of an agreement or Memorandum of 
Understanding that should cover issues on access to the genetic resources (biodiversity), 
on intellectual property related to discovery, on the sharing of benefits as part of the 
process (short term), and in the event of discovery and commercialization of a product 
(long term), as well as on the conservation of the biological resources for the future 
generations. When ethno botanical or ethno pharmacological approach is utilized, 
additional specific requirements that relate to prior informed consent, recognition of 
Indigenous Intellectual Property and Indigenous Intellectual Property Rights as well as 
short- and long-term benefit sharing need to be taken into account. 
In order to screen thousands of plant species at one go for as many bioassays as 
possible, we must have a collection of a large number of extracts. Globally, there is a 
need to build natural products extract libraries. The extract libraries offer various 
advantages, such as reduction in cost and time for repeat collection of plants and 
availability of properly encoded and preserved extracts in large numbers for biological 
screening in terms of high-throughput screenings and obtaining hits within a short period. 
Such libraries could serve as a powerful tool and source of extracts to be screened for 
biological activities using high-throughput assays.6
 
DRUG DISCOVERY FROM NATURAL SOURCES 
For thousands of years, natural products have played an important role throughout the 
world in treating and preventing human diseases and disorders. The importance of natural 
products in modern medicine has been discussed in recent reviews and reports. The value 
of natural products in this regard can be assessed mainly by using three criteria: 
1. The rate of introduction of new chemical entities of wide structural diversity, 
including serving as lead molecule for semi-synthetic and total synthetic 
modification 
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     2. The number of diseases treated or prevented by these substances, and 
     3. Their frequency of use in the treatment of disease. 
An analysis of the origin of the drugs developed between 1981 and 2003 showed that 
natural products or natural product-derived drugs comprised 28% of all new chemical 
entities (NCEs) launched onto the market. In addition, about 24% of these NCEs were 
synthetic or natural mimic compounds, based on the study of pharmacophores related to 
natural products. This combined percentage suggests that the  natural products are 
important  sources  for  new  drugs  and  are  also  good lead compounds suitable for  
further modification during drug discovery and development.7 
CANCER 
Cancer is a group of diseases involving abnormal cell growth with the potential to 
invade or spread to other parts of the body. These contrast with benign tumors, which do 
not spread to other parts of the body. Possible signs and symptoms include a lump, 
abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel 
movements. While these symptoms may indicate cancer, they may have other causes. 
Over 100 types of cancers affect humans.8 
Tobacco use is the cause of about 22% of cancer deaths. Another 10% are due 
to obesity, poor diet, lack of physical activity, and excessive drinking of alcohol. Other 
factors include certain infections, exposure to ionizing radiation and environmental 
pollutants. In the developing world, 15% of cancers are due to infections such as 
Helicobacter pylori, hepatitis B, hepatitis C, human papilloma virus infection, Epstein–
Barr virus and human immunodeficiency virus. These factors act, at least partly, by 
changing the genes of a cell. Typically many genetic changes are required before cancer 
develops9. Approximately 5–10% of cancers are due to inherited genetic defects from a 
person's parents. Cancer can be detected by certain signs and symptoms or screening 
tests. It is then typically further investigated by medical imaging and confirmed 
by biopsy.10 
Many cancers can be prevented by not smoking, maintaining a healthy weight, not 
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drinking too much alcohol, eating plenty of vegetables, fruits and whole 
grains, vaccination against certain infectious diseases, not eating too 
much processed and red meat, and avoiding too much sunlight exposure. Early detection 
through screening is useful for cervical and colorectal cancer. The benefit of screening 
in breast cancer is controversial. Cancer is often treated with some combination 
of radiation therapy, surgery, chemotherapy, and targeted therapy. Pain and symptom 
management are an important part of care. Palliative care is particularly important in 
people with advanced disease. The chance of survival depends on the type of cancer and 
extent of disease at the start of treatment. In children under 15 at diagnosis the five-year 
survival rate in the developed world is on average 80%. For cancer in the United States 
the average five-year survival rate is 66%.11 
In 2015, about 90.5 million people had cancer. About 14.1 million new cases 
occur a year (not including skin cancer other than melanoma). It caused about 8.8 million 
deaths (15.7% of deaths). The most common types of cancer in males are lung 
cancer, prostate cancer, colorectal cancer and stomach cancer. In females, the most 
common types are breast cancer, colorectal cancer, lung cancer and cervical cancer. If 
skin cancer other than melanoma were included in total new cancers each year, it would 
account for around 40% of cases. In children, acute lymphoblastic leukemia and brain 
tumors are most common except in Africa where non-Hodgkin lymphoma occurs more 
often. In 2012, about 165,000 children under 15 years of age were diagnosed with 
cancer12. The risk of cancer increases significantly with age and many cancers occur 
more commonly in developed countries. Rates are increasing as more people live to an 
old age and as lifestyle changes occur in the developing world. The financial costs of 
cancer were estimated at $1.16 trillion USD per year as of 2010. 
TYPES OF CANCER 
Our bodies are made up of billions of cells. The cells are so small that they can 
only be seen under a microscope. These cells are grouped together to make up the tissues 
and organs of our bodies. These cells are basically the same, but they vary in some ways. 
This is because the body organs do very different things.13 For example; nerves and 
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muscles do very different things. So nerve and muscle cells have different structures. 
Cancers can be grouped according to the type of cell they start in. There are 5 
main categories 
1. Carcinoma – cancer that begins in the skin or in tissues that line or cover 
internal organs. There are a number of subtypes, including adeno carcinoma, basal cell 
carcinoma, squamous cell carcinoma, and transitional cell carcinoma 
2. Sarcoma – cancer that begins in the connective or supportive tissues such as 
bone, cartilage, fat, muscle, or blood vessels 
3.  Leukemia – cancer that starts in blood forming tissue such as the bone marrow 
and causes large numbers of abnormal blood cells to be produced and go into the blood 
4.   Lymphoma and myeloma – cancers that begin in the cells of the immune 
system 
5.  Brain and spinal cord cancers – these are known as central nervous system 
cancers 
Cancers can also be classified according to where they start in the body, such as 
breast cancer or lung cancer.14 
 
SIGNS AND SYMPTOMS15 
Roughly, cancer symptoms can be divided into three groups. 
LOCAL SYMPTOMS 
Unusual lumps or swelling (tumour), hemorrhage (bleeding), pain and / or 
ulceration. Compression of surrounding tissues may cause symptoms such as jaundice 
SYMPTOMS OF METASTASIS (SPREADING) 
Enlarge lymph nodes, cough and haemoptysis, hempatomegaly (enlarged liver), 
bone pain, fracture of affected bones and neurological symptoms.  Although advanced 
cancer may cause pain, it is often not the first symptom. 
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SYSTEMIC SYMPTOMS 
Weight loss, poor appetite and cachexia (wasting), excessive sweating (night 
sweats), anaemia and specific para-neoplastic phenomena, i.e., specific conditions that 
are due to an active cancer, such as thrombosis or hormonal changes.  
CANCER CELL CYCLE15 
s  
Figure 2: CANCER CELL CYCLE 
Cellular multiplication involves passage of the cell through a cell cycle.  The 
various phases of the cell cycle are characterized as:  (i) the interval follow cell division 
to the point where DNA synthesis starts, known as the pre-synthetic phase (G1).  The 
variability in the length of the cell cycle between rapidly and slowly replicating cells is 
accounted by the differences in the length of (G1) phase; (ii) after mitosis some of the 
daughter cells pass into a resting phase or non-proliferative. 
Phase (G0), and do not re-enter the cell cycle phase G1 immediately.  They may 
enter the G1 phase later.  The G0 phase is the sub phase of G1; (iii) the DNA synthesis(s) 
occurs; (iv) the pre mitotic or post synthetic (G2) phase follows.  In the phase RNA and 
protein synthesis take place, and it is shorter than the S phase; and (v) lastly mitotic (M0 
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phase follows, in which the synthetic activity of the cell is low the chromosomes separate 
in two daughter cells through the sub phase-prophase, metaphase, anaphase and telo 
phase.  These daughter cells have the option of either entering the G1 phase or the G0 sub 
phase of G1 phase. 
Cancers are caused by a series of mutations.  Each mutation alters the behaviour 
of the cell somewhat. Carcinogenesis, when means the initiation or generation of cancer, 
is the process of derangement of the rate of cell division due to damage to DNA.  Proto-
oncogenes are genes which promote cell growth and mitosis, a process of cell division, 
and tumour suppressor genes discourage cell growth, or temporarily halt cell division in 
order to carry out DNA repair.  Typically, a series of several mutations to these genes are 
required before a normal cell transforms into a cancer cell. 
Proto-oncogenes promote cell growth through a variety of ways.  Many can 
produce hormones, a “chemical messenger” between cells which encourage mitosis, the 
effect of which depends on the signal transduction of the receiving tissue or cells.  Some 
are responsible for the single transduction system and signal receptors in cells and tissues 
themselves, thus controlling the sensitivity to such hormones. 
They often produce mitogens, or they are involved in transcription of DNA in 
protein synthesis, which creates the proteins and enzymes responsible for producing the 
biochemical cells use and interact with Mutation sin proto-oncogenes can modify their 
expression and function, increasing the amount or activity of the product protein.  When 
this happens, they become oncogenes, and thus cells have a higher chance to divide 
excessively and uncontrollably.  The chance of cancer cannot be reduced by removing 
proto oncogenes from the genome as they are critical for growth, repair and homeostasis 
of the body. 
CHEMOTHERAPY16, 17 
Chemotherapy plays a significant role in the treatment of early stage disease, in 
the pro-operative period and as adjuvant therapy for the treatment of micro metastasis.  
As knowledge has been accumulating in the area of pharmacology, tumour biology, 
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cytokine ties and resistance, therapeutic strategies have been developed that maximize the 
tumour-cell kill, decrease resistance and enhance the potential for cure by chemotherapy.  
The antineoplastic armamentarium currently contains over 30 drugs, with many 
additional agents under investigation.  Human pituitary growth hormone, prostaglandins, 
cyclin-AMP, RNA-dependent DNA polymerase, etc also show promising results. 
Since the differences between normal and neoplastic human cells are merely 
quantitative rather than qualitative, most antineoplastic drugs are associated with certain 
side effects.  The toxicity usually involves attack of drugs on rapidly proliferating normal 
body tissues such as bone marrow, hair follicles and intestinal epithelium. In addition, 
individual drug may produce its own distinctive toxic effects on heart, lungs, kidneys and 
other organs.  Hence with some exceptions it can be said that the antineoplastic agents are 
generally palliative and not curative. 
Many anti-cancer drugs (a) have a very narrow therapeutic index (b) is highly 
unable (c) are effective at very low concentration and (d) having unusual metabolic 
pathways. 
DRUG DESIGNING FOR CANCER18 
 In designing specific regimens for clinical use, a number of factors must be taken 
into account.  Drugs are generally more effective in combination and may be synergistic 
through biochemical interactions.  These interactions are useful designing new regimens.  
It is more effective to use drugs that do not share common mechanisms of resistance and 
that do not overlap in their major toxicities.  Drugs should be used as close as possible to 
their maximum individuals does.  And, finally, drugs should be used as close as possible 
to discourage tumour growth and maximize does intensity (the does gives per unit time, a 
key parameter in the success of chemotherapy).  Based on experimental tumour models, 
it is necessary to eradicate all tumour cells.  The fraction of cells killed with each 
treatment cycle is constant, with re growth between cycles.  Thus, it is desirable to 
achieve maximal cell kill with each cycle, using the highest drug does possible, and to 
repeat does ad frequently as tolerated.  Since the tumour cell population in patients with 
visible disease exceeds 1gm, or 109 cells, and since each cycle of therapy kills less than 
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99% of the cells, it is necessary to repeat treatment in multiple cycles to kill all the 
tumour cells. 
THE MECHANISM ON CANCER THERAPY18 
1. Inhibiting cancer cell proliferation directly by stimulating macrophage phagocytosis, 
enhancing natural killer cell activity. 
2. Promoting apoptosis of cancer cells by increasing production of interferon, 
interleukin-2 immunoglobulin and complement in blood serum. 
3. Enforcing the necrosis of tumor and inhibiting its translocation and spread by 
blocking the blood source of tumor tissue. 
4. Enhancing the number of leukocytes and   platelets by stimulating the hemopoietic 
function. 
5. Promoting the reverse transformation from tumor cells into normal cells. 
6. Promoting metabolism and preventing carcinogenesis of normal cells. 
7. Stimulating appetite, improving quality of sleep, relieving pain, thus benefiting 
patient’s health. 
PLANTS: TREATMENT OF CANCER19 
In the face of failure to fine synthetic drugs against cancer, thousands species of 
plants have been screened since a long time, for anti-neoplastic activity, in the hope of 
discovering effective natural products.  Compounds have been evaluated.  Such work is 
still going on in several laboratories throughout the world.    
The Natural Product Drug Development Program of the U.S. National Cancer 
Institute has identified about 3000 species of plants and animals as useful in dealing with 
one or the other aspect of cancer management.  Based on in vitro data, a large number of 
species have been identified to be of promise and taken to clinical trials.   
However, products of hardly a handful of plant species, such as the Vinca 
alkaloids, Taxol, Camptothecin, Podophyllotoxin, etc., have passed through the rigorous 
tests to be officially used against certain types of cancer and are now available in the 
market. Yet there are severe problems associated with the use of even these largely 
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‘successful’ drugs, which are among the most expensive plant products.  This reflects the 
complexity of the scenario of cancer drugs in general and plant base. 
EVALUATION OF ANTICANCER STUDIES19 
Anticancer drugs can be evaluated by in vitro and in vivo methods. 
IN VITRO METHODS: CYTOTOXICITY 
There is much pressure, both human and economic, to perform at least part of 
cytotoxicity testing in vitro.  Currently it is difficult to monitor systematic and 
physiological effects in vitro, so most assay determine effects at cellular level, or 
cytotoxicity broadly involve the metabolic alternation of the cells, including the death of 
cells as a result of toxic effects of the compounds. 
The choice of assay will depend on agent on study, the nature of response, and the 
particular target cell. In anticancer research, the in vitro screening involves estimation of 
cytotoxicity of the drug by different methods.  The commonly used methods of studying 
cytotoxicity are. 
DETERMINATION OF CELL VIABILITY BY TRYPHAN BLUE DYE 
EXCLUSION METHOD 
In this method, viability dyes such as tryphan blue is used to determine membrane 
integrity.  Staining for viability assessment is more suited to suspension culture than to 
monolayer, because dead cells detach from the monolayer and are therefore lost from the 
assay.  The method has been applied with equal success to solid tumor, effusions and 
haematological malignancies. 
DETERMINATION OF CELL VIABILITY BY UPTAKE OF NEUTRAL RED 
DYE BY THE LYSOSOME IN NEUTRAL RED ASSAY 
The uptake of neutral red by lysosome and Golgi bodies has been used to 
quantitative cell number.  The satin appears to be specific for viable cells, but the main 
limitation of the method is the difference in uptake between cell types.  Thus some cell 
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types.  Thus some cell types, such as activated macrophages and fibroblast take up 
amount very rapidly where as others, such as lymphocytes, show negligible staining. 
DETERMINATION OF CELL METABOLIC FUNCTION BY PROTEIN 
ESTIMATION 
Several methods are available for measuring the protein contents of cell 
monolayers.  These include the use of Folin-ciocatechu reagent according to the method 
of Lowry and amino black. 
DETERMINATION OF QUANTITATIVE VALUE FOR THE LOSS OF CELL 
VIABILITY BY MEASUREMENT OF LACTATE DEHYDROGENASE 
ACTIVITY BY LDH ASSAY 
The measurement of lactate dehydrogenase in culture supernatant gives a 
quantitative value for the loss of cell viability. 
Pyruvate + NADH + H +  NAD+ + lactate 
The activity of LDH can be measured as the reduction of Pyruvate to lactate.  The 
reduction is coupled to the oxidation of NADH to NAD, which is followed 
spectrophotometrically at 340nm. 
SULPHOROMAMINE B (SRB) ASSAY 
SRB is a pink amino xanthenes dye with two sulfonic groups.   Under mild acidic 
condition, SRB binds to protein basic amino acid residue in (trichloroacetic acid) fixed 
cells to provide a sensitive index of cellular protein content that is linear over a cell 
density range of visible at least two order of magnitude.  Colour development of SRB 
assay is rapid, stable, and visible.  The developed colour can be measured over a broad 
range of visible wavelength in 90-microliter plate readers. 
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CYTOTOXICITY BY MICRO CULTURE TETRAZOLIUM (MTT) ASSAY 
The ability of the cell to survive a toxic insult has been the basis of most 
Cytotoxic assays.  This assay is based on the assumption that dead cell or their products 
do not reduce Tetrazolium salt (3-(4, 5 dimethyl thiazole – 2yl) –2, 5 – diphenyl 
Tetrazolium bromide) into a blue colored product (formazan) by mitochondrial enzyme 
succinate dehydrogenase.  The numbers of cell are found to be proportional to the extent 
of formazan production by cells used 
IN VIVO METHODS 
❖ Fibro sarcoma solid tumour model. 
❖ EAC model (Ehrlich ascites carcinoma). 
❖ Chemically induced cancer model. 
❖ Virus induced cancer model. 
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2. LITERATURE REVIEW 
Julalak Chokpaisarn et al (2018)., studied the Quercus infectoria inhibits 
Set7/NF-κB inflammatory pathway in macrophages exposed to a diabetic environment.20 
Ahmed A Tayel et al (2018)., reported the application of Quercus infectoria 
extract as a natural antimicrobial agent for chicken egg decontamination.21 
Gamboa-Gómez et al (2017)., was studied the in vitro and in vivo assessment of 
anti-hyperglycemic and anti-oxidant effects of oak leaves 
(Quercus convallata & Quercus arizonica) infusions and fermented beverages.22 
Misba Naim et al (2017) reviewed Quercus infectoria (mazu).23 
Baharuddin NS et al (2015)., Anti-candida activity of Quercus infectoria gall 
extracts against Candida species.24 
Savitri Shrestha et al (2014)., has been reported pharmacognostic studies of 
insect gall of Quercus infectoria Olivier (Fagaceae).25 
Saeida et al (2014)., reported the potential use of Quercus infectoria galls extracts 
against urinary tract pathogenic bacteria.26 
Nur Syukriah AR et al (2014). Effect of solvent extraction on antioxidant and 
antibacterial ativities from Quercus infectoria (Manjakani).27 
Saini R & Patil SM (2012)., evaluated the anti-diabetic activity of roots of 
Quercus infectoria Olivier in alloxan induced diabetic rats.28 
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Rehman M et al (2012)., reported chemoprevnetive effect of Quercus infectoria 
against chemically induced renal toxicity and carcinogenesis.29 
Lodhi G et al (2012)., studied the hepatoprotective effects of Quercus infectoria 
gall extract against carbon tetrachloride treated liver injury in rats.30 
Nagesh et al (2012)., reported the antibacterial potential of gall extract of 
Quercus infectoria against Enterococcus faecalis-an in vitro study. Methanol extract of 
galls of Quercus infectoria was found to possess antibacterial property against 
Enterococcus faecalis. 31 
Hermizi Hapidin et al (2012)., had evaluated the potential role of Quercus 
infectoria gall extract on osteoblast function and bone metabolism.32 
Leela T & Satirapipathkul C (2011)., studied the antibacterial activity of Quercus 
infectoria Galls33  
Nuntana Aroonrerk & Narisa Kamkaen (2009)., investigated in the anti-
inflammatory activity of Quercus infectoria, Glycyrrhiza uralensis, Kaempferia galanga 
and Coptis chinensis, the main components of Thai herbal remedies for aphthous ulcer.34 
Aivazi AA & Vijiyan VA (2009)., studied the larvicidal activity of oak Quercus 
infectoria Oliv. (Fagaceae) gall extracts against Anopheles stephensi Liston.35 
Umachigi SP et al (2008)., studied wound healing properties of Quercus 
infectoria.36 
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Chusri S & Voravuthikunchai  SP (2008)., studied the Quercus infectoria 
Olivier (nutgalls) as an alternative treatment for methicillin-resistant Staphylococcus 
aureus infections.37 
Jae-Kwan Hwang et al (2004)., has been reported as anti-carcinogenic activity of 
some tropical medicinal plants against streptococcus mutans.38 
Kaur G et al (2004)., reported the anti-inflammatory evaluation of alcoholic 
extract of galls of Quercus infectoria.39 
Dar M & Ikram M (1979)., studied the Quercus infectoria; Isolation of syringic 
acid and determination of its central depressive activity.40 
 
CHAPTER 3 
 
 
 
 
 
 
 
 
 
PLANT PROFILE  
3. PLANT PROFILE 
Department of Pharmaceutical Chemistry Page 20 
3. PLANT PROFILE 
 
 
 
Figure 3: Seeds of Quercus infectoria 
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Taxonomical Classification 
Kingdom  :  Plantae 
Subdivision  :          Angiospermae  
Class   :      Eudicots 
Sub lass  :  Asterids 
Family   :  Fagaceae 
Genus   :  Quercus  
Species              :            Quercus infectoria 
 Vernacular Names  
Tamil       :  Masikkai, Machakai 
English        :  Oak gall, Magin gall, Dyers’ Gall Magic Nut  
Telugu          :  Mashikaya 
Malayalam   :  Manja-kani 
Sanskrit       :  Machika 
            Hindi           :  Machika 
MORPHOLOGY 
  The plant Quercus infectoria (Family-Fagaceae) grows as a shrub or small tree, 
diclinous and monoecious. It is about 2.5 m in height with many spreading branches. 
Bark is slightly greyish in colour. Leaves are rigid, glabrescent with spinous teeth 
measuring 4-6 cm in length; acorns cylindrical. They are alternate, short petiolate, 
elongate, sinuate, roughly thorny-tipped serrate. Flowers are unisexual. The male flowers 
are tangled into hanging, axillary catkins, with 6-8 tepaledperigone and 6 to 10 stamens. 
The female flowers are single or in small groups in the leaf axils of dropping stipules. 
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The perigone is 6-tipped with an inferior 3chambered ovary surrounded by an initially 
inconspicuous and then later cup shaped cupula. Fruits are globose, 0.63 cm, lemon in 
colour and tingled yellow. 
 This tree grows in Greece, Asia Minor, Syria and Persia. Usually it does not grow in 
India and are imported but they may be found in Garhwal Himalayas and Nepal .The 
various Quercus species are originated in Iran, Iraq and Turkey, but are now widespread 
and particularly common in Asia Minor, Europe and North Africa. They are found 
throughout the Northern Hemisphere, in woods, forest and long hedgerows. There are 
various trade names of galls which are exported to India and other countries like Aleppo 
Gall, Mecca Gall, Turkey Gall, Levant Gall, Smyrna Gall, Syrian Gall etc. These all 
varieties vary in their general appearance, colour and size. Aleppo galls from Asia Minor, 
is considered to be of best quality and have highest tannin content. The galls obtained 
from Eastern Europe are commonly known as Knoppers or Acorn Galls and are mainly 
formed on Quercus arbour and other species. They are quite different in appearance from 
those of Aleppo or Turkish galls. The Basso rah Galls are collected from Tigris or 
Euphrates rivers in Iraq and shipped frequently to Mumbai are sometimes re-exported as 
Bombay or Indian Galls. Some galls which are employed in India may be collected from 
indigenous oaks are found in Kumauni, Garhwal and Bijnor forests. 
Chemical Constituents: 
 The galls from Quercus infectoria contain the highest naturally occurring level of 
tannin, approx. 50–70%, syringic acid, β-sitosterol, amentoflavone, hexamethyl ether, 
isocryptomerin, methyl betulate, methyl oleanate and hexagalloyl glucose. They also 
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contain 2-4% each of gallic and ellagic acid that are polymerized to make 
tannins. Tannins have been used for hundreds of years for medical purposes and are 
currently indispensable in dermatology and have been used for tanning of leather. 
Medicinal uses 
The galls are considered as an astringent, acrid, cooling, haemostatic, 
constipating, vulnerary, expectorant, digestive, febrifuge, trichogenous and tonic. It is 
much revered for its strong astringent properties and is used mainly to treat conditions 
where this property is advantageous. 
The powdered gall mixed with alum and tied in a muslin gauze used to be inserted 
into the vagina to help regression of prolapsed uterus. It is also used in the form of a 
vaginal douche to treat leucorrhoea, atonic menorrhagia and prolapsed of the uterus. An 
ointment applied in the vaginal canal was used to treat vaginal laxity. 
As a strong astringent the decoction is used to treat diarrhoea and dysentery per 
oral. It is also used to treat all degrees of haemorrhoids, anal fissures and prolapsed 
rectum whence the decoction is applied locally as washings or incorporated in sitz’s bath. 
There are also ointments prepared with powders of Oak galls incorporated into it as a 
local application for these anal diseases. 
Oak gall has been incorporated into dental powders. This helps in strengthening 
gums and teeth. For throat infection like tonsillitis and stomatitis effectively a gargle was 
prescribe made from decocting oak galls.  Decoction of Q. infectoria gall is used as an 
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antidote to various plants poisons especially those due to alkaloids e.g. Opium, nux-
vomica, aconite. It is also used in cases of poisoning by emetine or tartar emetic.  
As a strong astringent the Oak Gall has many applications in skin problems. It has 
been used to promote healing of wounds from cuts, skin infections. It also treats 
impetigo, eczema, hyper hydroid and chapped nipples. Ringworm and alopecia was 
treated by Unani physicians by making use of oak gall soaked in vinegar.20-40 
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4. AIM AND PLAN OF WORK 
 Quercus infectoria is a well known Siddha medicine, the roots, leaves and the 
galls are considered as an astringent, acrid, cooling, haemostatic, constipating, vulnerary, 
expectorant, digestive, febrifuge, trichogenous and tonic.  
It is much revered for its strong astringent properties. As a strong astringent the 
decoction is used to treat diarrhea and dysentery per oral. It is also used to treat all 
degrees of hemorrhoids, anal fissures and prolapsed rectum. 
 Oak gall has been incorporated into dental powders. This helps in strengthening 
gums and teeth. Looking to the scope of herbal drug and increasing demand especially in 
case of diseases like liver disorders, hypertension, diabetes, cancer, diarrhoea, arthritis 
and skin diseases, etc., it was planned to study a plant like Quercus infectoria, which is 
having a variety of traditional uses.  
This plant is selected for present study based on its easy availability; degree of 
research work which is not done. The literature survey revealed that some amount of 
pharmacological work has been carried out on Quercus infectoria.  
The present study was aimed to carry out phytochemical analysis and 
pharmacological screening of seeds of Quercus infectoria. So in order to explore the 
activities and phytoconstituents present in the seeds of Quercus infectoria, planned to go 
for the following studies. 
 
4. AIM AND PLAN OF WORK 
Department of Pharmaceutical Chemistry Page 26 
 
PLAN OF WORK  
 The work was planned as under mentioned 
PHYTOCHEMICAL STUDIES 
❖ Collection and authentication of plant material. 
❖ Extraction of the plant material. 
❖ Preliminary phytochemical screening of the extract. 
❖ Thin layer chromatography of the extract. 
❖ Isolation of plant constituent by column chromatography. 
❖ Characterization of isolated compound by IR, NMR, Mass Spectra. 
PHARMACOLOGICAL STUDIES  
➢ In vitro anti-cancer activity 
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Table 1: Chemicals 
S. No. Chemicals Supplier/ manufacture 
1. Petroleum ether (60 - 80 ºC) Loba chemical pvt.ltd., Mumbai 
2. Ethanol (95 %) Merck-Schuchardt, Mumbai 
3. Silica gel-G (TLC grade) Loba chemical pvt.ltd., Mumbai 
 4. Silica gel G (60 - 120 mesh) E merck- Germany 
 5. Hexane Loba chemical pvt.ltd., Mumbai 
6. Ethyl acetate Loba chemical pvt.ltd., Mumbai 
 
Table 2: Instruments and Equipments 
S. 
No. 
Equipments/Instruments Model Manufacture 
1. Hot air oven Geninuine 
Shivani Scientific 
industries 
2. 
Electronic weighing 
Balance 
BT 2245 Surtorius 
3. Melting point apparatus MRVIS Lab India 
4. IR Spectrophotometer 
Bruker optik  
GMBH 
Germany 
5. NMR- Spectrophotometer 
Bruker AVIII 
Avance FT  NMR 
Germany 
6. Mass spectrophotometer JEOL GCmate Germany 
7. Soxhlet apparatus Borosil Chennai 
 
COLLECTION OF PLANT 
 The seeds of Quercus infectoria was collected from Siddha Medical Shop, 
Madurai, Tamilnadu, India and the specimen was preserved in our Pharmacognosy Lab, 
JKKN College of Pharmacy, Komarapalayam for further reference. 
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AUTHENTICATION OF PLANT 
The plant was authenticated by Dr. D. Stephen, M.Sc, Ph.D., Professor, 
Department of Botany, The American College, Madurai-625002, Tamilnadu. 
EXTRACTION PROCEDURE 
The seeds of Quercus infectoria were dried under shade and then made in to a 
coarse powder with a mechanical grinder.  The powder was passed through sieve no. 40 
and stored in an airtight container for further use.  The dried powder material (200 gm) 
was extracted with ethanol (95 % v/v) in a soxhlet extractor for 72 hr.  The solvent was 
then distilled off and the resulting semisolid mass was dried in a vacuum evaporator and 
yield was calculated. 
PRELIMINARY PHYTOCHEMICAL ANALYSIS41-44   
 The extract of Quercus infectoria was subjected to qualitative tests for the 
identification of various phytoconstituents. 
1) TEST FOR ALKALOIDS 
(a) Dragendorff’s test: 1 ml of the extract was added with 1 ml of Dragendorff’s 
reagent (potassium bismuth iodide solution). An orange red precipitate indicates the 
presence of alkaloids. 
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(b) Mayer’s Test: 1 ml of the extract was added with 1 ml of Mayer’s reagent 
(potassium mercuric iodide solution). Whitish yellow colored precipitate indicates 
the presence of alkaloids. 
(c) Hager’s Test: 1 ml of the extract was added with 3 ml of Hager’s reagent (saturated 
aqueous solution of picric acid), yellow colored precipitate indicates the presence of 
alkaloids. 
(d) Wagner’s Test: 1 ml of the extract was added with 2 ml of Wagner’s reagent 
(Iodide in potassium Iodide), formation of reddish brown precipitate indicates the 
presence of alkaloids. 
(e) Tannic acid Test: 1 ml of the extract was added with 1 ml of 10% tannic acid 
solution, buff colored indicates the presence of alkaloids. 
2) TEST FOR SAPONINS 
(a) Foam Test: The extract was diluted with 20 ml of distilled water and shaken in a 
graduated cylinder for 15 min lengthwise. A 1 cm layer of foam indicates the 
presence of Saponins. 
(b) Lead acetate Test: 1 ml of sample solution was treated with 1% lead acetate 
solution, formation of white precipitate indicate the presence of saponins. 
(c) Hemolytic Test: The extract or dry powder was added one drops of blood placed on 
glass slide. If hemolytic zone appears shows the presence of saponins. 
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3) TEST FOR GLYCOSIDES 
(a) Legal’s Test: Dissolved the extract in pyridine and added sodium nitroprusside 
solution to make it alkaline. The formation of pink red to red color shows the 
presence of glycosides.  
(b) Baljet Test: 1 ml of the test extract was added with 1 ml of sodium picrate solution 
and the yellow to orange color shows the presence of glycosides. 
(c) Keller- Killiani Test: The ethanol extract 0.5 ml of strong solution of lead acetate 
was added and filtered. The filtrate is shaken with 5 ml of chloroform. The 
chloroform layer is separated in a porcelain dish and removes the solvent by gentle 
evaporation. Dissolve the cool residue in 3 ml of glacial acetic acid containing 2 
drops of ferric chloride solution. Carefully transferred this solution to the surface of 
2 ml of concentrated sulphuric acid. A reddish brown layer forms at the junction of 
the two liquids and the upper layer slowly becomes bluish green, darkening with 
standing. 
(D) Borntrager’s Test: Added a few ml of dilute sulphuric acid to 1 ml of the extract 
solution. Boiled filtered and extracted the filtrate with chloroform the chloroform 
layer was treated with 1 ml of ammonia. The formation of red color of the 
ammonical layer shows the presence of anthra quinone glycosides. 
4) TEST FOR CARBOHYDRATES AND SUGARS 
(a) Molisch’s Test: 2 ml of the extract was added with 1 ml of α- napthol solution was 
added and also added concentrated sulphuric acid through the side of the test tube. 
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Reddish violet color at the junction of the two liquids indicates the presence of 
carbohydrates. 
(b) Fehling’s Test: 1 ml of the extract was added with equal quantities of Fehling 
solution A and B were added, upon heating formation of a brick red precipitate 
indicates the presence of reducing sugars. 
(c) Benedict’s test: 1 ml of extract was added with 5 ml of benedicts’ reagent, was 
added and boiled for 2 min. and cool. Formation of red precipitate shows presence 
of sugars.  
(d) Tollen’s Test: 1 ml of extract was added with 2 ml of tollen’s reagent was added 
and boiled. A silver mirror is obtained inside the wall of the tube which indicates 
the presence of aldose sugar. 
(e) Seliwanoff’s Test: The extract was treated with hydrochloric acid and resorcinol 
and heated. Formation of red color shows presence of glucose. 
(f) Bromine water Test: The little quantity of test extract, bromine water was added. 
Bromine water decolourization indicates the presence of aldose sugar. 
 5) TEST FOR TANNINS 
(a) Gelatin Test: 1 ml of extract was added with 1% gelatin solution containing 10% 
sodium chloride. Formation of white precipitate indicates the presence of tannins. 
(b) Ferric chloride Test: 1 ml of extract was added with 1ml ferric chloride solution, 
formation of dark blue or greenish black product shows the presence of tannins. 
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(c) Vanillin hydrochloride Test: 1 ml of extract was added with vanillin 
hydrochloride. Formation of purplish red color indicates the presence of tannins. 
(d) Lead acetate Test: Taken a little quantity of test solution was taken and mixed with 
basic lead acetate solution. Formation of white precipitate indicates the presence of 
tannins. 
(e) A little quantity of test extract was treated with potassium ferric cyanide and 
ammonia solution. A deep red color indicates the presence of tannins. 
(f) Potassium dichromate Test: The sample solution was treated with 1ml of 10% 
Potassium dichromate solution gives yellowish brown precipitate indicates the 
presence of tannins. 
6) TEST FOR FLAVONOIDS 
(a) Shinoda’s Test: The extract solutions, few fragments of magnesium ribbon was 
added and add concentrated HCL drop wise gives cherry red color appears after few 
minutes, shows the presence of flavanoids. 
(b) Alkaline reagent Test: The extract was treated with sodium hydroxide; formation of 
yellow color indicates the presence of flavanoids. 
(c) Little quantity of extract was treated with lead acetate, a yellow color solution 
formed, disappears on addition of an acid indicates the presence of flavanoids. 
(d) The extract was treated with concentrated sulphuric acid, formation of yellow or    
orange color indicates the presence of flavanoids. 
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7) TEST FOR STEROIDS 
(a) Libermann- Bur chard’s Test: 2 ml of extract was added with chloroform solution, 
1-2 ml of acetic anhydride and 2 drops of concentrated sulphuric acid was added 
along the sides of the test tube. Appearance of bluish-green color shows the presence 
of steroids.  
(b) Salkowsky’s Test: Dissolve the extract in chloroform solution, 2 ml conc. sulphuric 
acid was added. If chloroform layer appear red color indicate the presence of 
steroids. 
8) TEST FOR PROTEINS AND AMINO ACIDS 
(a) Biuret Test: 1 ml of the extract was treated with 4% NaOH and few drops of CuSO4 
solution, Formation of purple violet color indicate the presence of proteins. 
(b) Ninhydrin Test: 1 ml of the extract was treated with 3 drops of 5% Ninhydrin 
solution in boiling water bath for 10 min; formation of purplish or bluish color 
appearance indicates the presence of proteins, peptides or amino acid. 
(c) Xanthoproteic Test: 1 ml of the extract was treated with 1 ml of concentrated nitric 
acid. A white precipitate formed, it was boiled and cooled. Then 20% of sodium 
hydroxide or ammonia is added. Orange color indicates the presence of amino acids. 
(d) Millon’s Test: 1 ml of the extract was treated with millon’s reagent (mercuric nitrate 
in HNO3) white precipitate turns to brick red indicate the presence of proteins. 
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9) TEST FOR TRITERPENOIDS 
(a) Knoller’s Test: Dissolved 2 or 3 granules of tin metal in 2 ml thionyl chloride 
solution. Then added 1 ml of the extract into the test tube and warm, the formation of 
pink color indicates the presence of Triterpenoids. 
10) TEST FOR FIXED OILS AND FATS 
(a) Spot Test: Pressed a small quantity of extract between two filter papers, the stain 
on the filter paper indicates the presence of fixed oils.  
(b) Saponification Test: Added a few drops of 0.5 N of alcoholic potassium hydroxide 
to small quantity of various extract along with a drop of phenolphthalein separately 
and heat on water bath for 1 to 2 hrs. The formation of soap or partial neutralization 
of alkali indicates the presence of fixed oils and fats. 
11) TEST FOR GUMS AND MUCILAGE 
 10 ml of extract was slowly added 25ml of absolute alcohol with constant stirring, 
filtered the precipitate and dried in air. The precipitate for its swelling property indicates 
the presence of carbohydrates. 
THIN LAYER CHROMATOGRAPHY45, 46 
 Thin layer chromatography as a procedure for analytical adsorption 
chromatography was first introduced by Stahl (1958) who was mainly responsible for 
bringing out standard equipment for preparing thin layers. It is not present an important 
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analytical tool for qualitative and quantitative analysis of a number of natural products, 
for separation and estimation of different components. 
 The principle of separation is adsorption.  One or more compounds are spotted on 
a thin layer of adsorbent coated on TLC plate.  The mobile phase flows through because 
of capillary action (against gravitational force).  The component moves according to their 
affinity towards the stationary phase.  The component with lesser affinity towards the 
stationary phase travels faster and vice versa thus leading to the separation of 
components.  The information provided by a finished chromatography includes the 
“migrating behavior” of the separated substances.  It is given in the form of Rf value 
(relative to front). 
Rf = solventbytravelledDistance
solutebytravelledDistance
 
Rf value usually lies in the range of 0.1 – 1. 
PROCEDURE 
1. Preparation of plate 
 The silica gel G (60-120 mesh) (Fischer & Co) was utilized for the preparation of 
TLC plates.  Silica gel G was mixed with sufficient quantity of water and triturated will 
to make slurry.  The prepared slurry was spread on the meticulously cleaned and scratch 
free glass plates of definite dimension by using a TLC spreader.  The thickness of the 
absorbent was adjusted to 2 mm throughout the plate.  Then the prepared plates were 
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allowed to set for 15-30 minutes.  The activated plates were stored in a vacuum 
desiccator for future use.  Also prior to use the plates were once again activated. 
2. Development of Chromatogram 
 The saturation of atmosphere of TLC chamber by mobile phase before the start of 
the experiment is almost important to avoid the flawed results due to tailing effect.  The 
sample was spotted on the plate 2 cm away from the bottom.  The plate was then 
developed in the chamber by allowing the plate to run up to ¾ th distance of the plate.  
The plate was then removed dried up to room temperature and sprayed with suitable 
spray reagent or kept in iodine chamber for identification of spots of TLC pattern of 95% 
v/v of ethanol extract of Quercus infectoria (EEQI). 
COLUMN CHROMOTAGRAPHY 47-49 
 The column chromatographic technique is widely used for separation, isolation, 
and purification of the natural products.  The principle underlying the separation of the 
compounds is adsorption at the solid liquid interface.  For the solid support and the 
interaction between adsorbent and component must be reversible.  As the adsorbent is 
washed with fresh solvent the various components will therefore move down the column 
until, ultimately, they are arranged in order of their affinity for the adsorbent.  Those with 
least affinity move down the column at a faster rate than, and are eluted from the end of 
the column before, those with greatest affinity for the adsorbent.  By changing the 
polarity of the mobile phase, the separation can be achieved by column chromatography.  
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Characterization of the isolated compounds can be carried out by analytical techniques, 
like IR, NMR and Mass spectroscopy. 
Details of Column Chromatography 
 On the basis of phytochemical screening and TLC study, the EEQI and the 
solvent system were selected for column chromatography by isocratic elution method. 
Details of column chromatography 
Adsorbent - Silica gel for column chromatography (60-120# mesh) 
Solvent system  - Toluene: Ethyl acetate (9 : 1) 
Length of column  - 60 cm 
Diameter of column  - 2 cm 
EELA used -  5 gm 
Rate of elution - 20 drops per minute  
Fraction collected - 40 fractions each of 25 ml 
Method of column packing - Wet packing 
Technique  -  Isocratic elution 
Procedure for preparation of column: 
1. The silica gel 60-120 mesh was made into slurry with selected solvent system 
(Toluene: Ethyl acetate (9 : 1), The silica gel previously activated by heating in hot 
air oven at 100 ºC for 1hr. 
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2. The bottom of the column was plugged by cotton and then the silica gel slurry was 
poured into the column which was filled with solvent system up to 40 cm height, after 
that it was set aside for 10 minutes and allowed to settle. 
3. EEQI was mixed with small amount of silica gel and wetted with solvent system and 
mixed well and allowed to evaporate the solvent to set the dry residue. 
4. Then the dry residue was charged on column with the help of solvent system, after 
that cotton was placed over it, in order to avoid the disturbance of the top layer of the 
adsorbent as fresh mobile phase was added to the column. 
5. The column was eluted with the selected solvent system by Isocratic method and the 
fractions were collected in clean 100 ml beaker up to 25 ml with the speed of drops 
was 20 drops/minute. 
Each collected fraction was tested for the presence of various constituents by TLC 
for the number of types of constituent and similar fractions were pooled together.  
SPECTRAL CHARACTERIZATION 
FT-IR Spectroscopy 
 Isolated compound was analysed by IR spectral studies by using KBr pellet 
technique. In this method, the drug and KBr were mixed at the ratio of 1:100. Then these 
mixtures were pressed in to a pellet. The FT-IR spectra were recorded for isolated 
compounds, using KBr pellet method in the region of 4000-400 cm-1.  
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NMR Spectroscopy 
 NMR is used to elucidate the structure of an unknown compound, there are three 
pieces of information which should be considered, the position of resonance of the peak 
(or chemical shift), the number of hydrogen atoms causing the signal (integration) and the 
number of peaks constituting the signal (multiplicity). NMR data to solve the structure 
but it is equally acceptable to use MS or IR data to solve the unknown. 
MASS Spectroscopy 
Mass spectrometry (MS) is an analytical technique that measures the mass-to-
charge ratio of charged particles. It is used for determining masses of particles, for 
determining the elemental composition of a sample or molecule, and for elucidating the 
chemical structures of molecules, such as peptides and other chemical compounds. The 
MS principle consists of ionizing chemical compounds to generate charged molecules or 
molecule fragments and measurement of their mass-to-charge ratios.50, 51 
PHARMACOLOGICAL STUDIES 
IN VITRO ANTICANCER ACTIVITY 
The human breast cancer cell line (MCF-7) and cervical cancer cell lines (HeLa) 
were obtained from National Centre for Cell Science (NCCS), Pune. The (MCF-7) cells 
were grown in Dulbecco’s modified eagles medium (DMEM) and HeLa cells were grown 
in Eagles minimum essential medium (EMEM) containing 10% fetal bovine serum 
(FBS). All cells were maintained at 37 oC, 5% CO2, 95% air and 100% relative humidity. 
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Maintained cultures were passaged weekly and the culture medium was changed twice a 
week. 
CELL TREATMENT PROCEDURE 
 The monolayer cells were detached with trypsin – ethylene diamine tetra acetic 
acid (EDTA) to make single cell suspensions and viable cells were counted using a 
haemocytometer and diluted with medium with 5% FBS to give final density of 1x105 
cells/ml. one hundred microlitres per well of cell suspension were seeded into 96-well 
plates at plating density of 10,000 cells/well and incubated to allow for cell attachment at 
37 oC, 5% CO2, 95% air and 100% relative humidity.  
After 24 hr the cells were treated with serial concentrations of the 95% v/v of 
ethanol extract of Quercus infectoria (EEQI). They were initially dissolved in 
dimethylsulfoxide (DMSO) and further diluted in serum free medium to produce five 
concentrations. One hundred microlitres per well of each concentration was added to 
plates to obtain final concentrations of 10, 20, 50, 100, 200 µg/ml. The final volume in 
each well was 200 µl and the plates were incubated at 37oC, 5% CO2, 95% air and 100% 
relative humidity for 48 hr. The medium containing without samples were served as 
control. Triplicate was maintained for all concentrations. 
MTT ASSAY 
 MTT is a yellow water soluble tetrazolium salt. A mitochondrial enzyme in living 
cells, succinate-dehydrogenase, cleaves the tetrazolium ring, converting the MTT to an 
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insoluble purple formazan. Therefore,the amount of formazan produced is directly 
proportional to the number of viable cells. 
 After 48 hr of incubation, 15 µl of MTT (5 mg/ml) in phosphate buffered saline 
(PBS) was added to each well and incubated at 37oC for 4 hr. The medium with MTT 
was then flicked off and the formed formazan crystals were solubilized in 100 µl of 
DMSO and then measured the absorbance at 570 nm using micro plate reader. The % cell 
inhibition was determined using the following formula.  
% cell Inhibition = 100- Abs (sample)/Abs (control) X 100.  
Nonlinear regression graph was plotted between percent cell inhibition was 
determined using Microsoft Excel software.52, 53 
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6. RESULTS AND DISCUSSION 
The seeds of Quercus infectoria belonging to family Fagaceae has been 
examined in a organized way covering phytochemical analysis and pharmacological 
screening. Litrerature survey revealed that not much work is done on this plant. 
Therefore, it was thought worthwhile to carry out the phytochemical analysis and 
pharmacological screening on this plant. 
PHYTOCHEMICAL STUDIES 
Extraction of Quercus infectoria seeds 
 Dried crushed seeds of Quercus infectoria were extracted with ethanol (95% 
v/v) continuously with soxhlet apparatus and the result was tabulated in Table 3. 
Table 3. Data showing the extractive values of seeds of Quercus infectoria 
S.No Extract Colour/ Physical nature 
Percentage 
yield (% w/w) 
1 Ethanol (95% v/v) Brownish yellow/ Solid 5.09 
 
Preliminary Phytochemical Screening of Quercus infectoria seeds 
95% v/v of ethanol extract of Quercus infectoria (EEQI) was subjected to 
qualitative phyto chemical screening to identify the phyto constituents present and the 
results were expressed in Table 4.
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      Table 4. Preliminary Phytochemical Screening of EEQI 
S. 
No. 
Chemical Test Ethanol  
(95% v/v)  extract 
1. Alkaloids  
a. Mayer’s Test - 
b. Dragendroff’s Test - 
c. Wagner’s Test - 
d. Hager’s Test - 
2. Carbohydrates  
a. Molisch’s Test + 
b. Fehlings Test + 
c. Barfoed’s Test + 
d. Benedict’s Test + 
3. Glycosides  
a. Legal’s Test - 
b. Keller-Killiani Test - 
c. Borntrager’s Test - 
4. Fixed Oil & Fat  
a. Stain Test - 
b. Saponification Test - 
5. Tanins & Phenolics  
a. Ferric Chloride Test + 
b. Lead Acetate Test + 
c. Gelatin Solution Test + 
6. Steroids  
a. Salkowsky’s Test + 
b. Libermann Burchard’s Test + 
7. Saponins  
a. Foam Test + 
8. Proteins  
a. Million’s Test - 
b. Ninhydrin Test - 
9. Flavonoids  
a. Aqueous NaOH Test + 
b. Conc.Sulphuric Acid Test + 
c. Shinoda Test + 
10. Gum & Mucilage - 
11. Triterpenoids  
a. Knoller’s Test + 
 
+ Present       - Absent 
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Thin Layer Chromatography (TLC) 
Figure 4. Thin Layer Chromatography of EEQI 
 
Table 5. Thin Layer Chromatography of EEQI 
Solvent system 
No. of 
spots 
Spray reagent Rf Values 
Ethyl acetate : Chloroform (6:4) 1 Iodine vapour 0.56 
Chloroform: Methanol (6:4) 1 Iodine vapour 0.59 
Hexane: Ethyl acetate (8: 2) 1 Iodine vapour 0.60 
 
0.62 
0.70 
 
 
 
 
TLC was performed with various solvent systems based on the polarity by trial 
and error method. EEQI was subjected to thin layer chromatography on silica gel G 
which had shown good resolution of solvent system Toluene: Ethyl acetate (8: 2). 
Two spots were identified by means of corresponding detecting agent and Rf values 
were calculated and showed in Table 5 and Figure 4. 
Toluene:  Ethyl acetate (8: 2) 2 Iodine vapour 
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Column Chromatography 
 
Table 6. Column Chromatography of EEQI 
Fraction 
No. 
Nature of 
Residue 
Analysis by 
TLC 
Colour of 
the spot 
Rf 
Value 
1-4 No residue --- --- --- 
5-8 No residue --- --- --- 
9-12 Brown --- --- --- 
13-16 Brown ---- --- --- 
17-20 Light Brown 2 spots with 
tailing effect 
Yellow 
Brown 
0.69 
0.72 
21-24 Brownish yellow ---- --- --- 
25-28 Light yellow 2 spots with 
tailing effect 
Yellow 
Brown 
0.69 
0.72 
29-32 No residue --- --- --- 
33-36 Brown 1 Pale brown  0.62 
37-40 No residue --- --- --- 
 
The isolated compound from the Fraction 33-36 obtained by column 
chromatography was named as EEQI-1. 
 
 
On the basis of phytochemical screening and TLC study, isolation of active 
constituents of  EEQI was done by column chromatography through isocratic elution 
technique  with  the  help  of  solvent  system Toluene:  Ethyl  acetate  (8:  2)  was 
shown in Table 6. 
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Characterization of EEQI-1 
Table 7. Chemical tests for EEQI-1 
Chemical Tests EEQI-1 
Ferric Chloride Test Positive 
Lead Acetate Test Positive 
 
Table 8. Physical Characters of EEQI-1 
 
 
 
 
 
 
Thin Layer Chromatography of the Isolated Compound EEQI-1 
Analysis of the isolated compound 
Parameters EEQI-1 
Yield 42 mg 
Physical state and colour Pale brown amorphous powder 
Solubility Water, Acetone and DMSO 
Melting point 258ºC 
TLC solvent system Toluene: Ethyl acetate (8: 2) 
Rf value 0.62 
 The isolated compound EEQI-1 obtained from column chromatography was 
analyzed by chemical tests, thin layer chromatography using the solvent system 
Toluene: Ethyl acetate (8: 2) and detected by iodine vapours.  EEQI-1 showed 
the presence of one yellow colour spot with Rf value of 0.62 was shown in Figure 5. 
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 The isolated compound from the seeds of Quercus infectoria was tested and it 
showed the positive test for phenolic compounds. The physical characters of the 
compound were tabulated above.
Figure 5. Thin Layer Chromatography of EEQI-1 
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Figure 6. IR Spectrum of isolated compound EEQI-1 
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Figure 7. 1H NMR Spectrum of isolated compound EEQI-1 
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Figure 8. Mass Spectrum of isolated compound EEQI-1
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Compound  EEQI-1 was obtained as pale brown amorphous powder and its 
molecular formula was established as C7H6O5 from its mass spectral data that 
showed [M-H]- ion at m/z 169.07, 153.12, 135.23 & 125.11. The molecular formula 
EEQI-1 was further supported by its IR, 1H NMR spectral data’s. The IR spectra 
exhibited characteristic bands at the strong and broad band between 3600 and 2500  
cm-1, the strong and narrow peak at 1704 cm-1could be assigned to the stretching 
vibration of OH group and carbonyl group, several peaks in 1310-1026 cm-1 region 
that could be assigned to the stretching vibration of C-O group and bending 
vibration of OH bond. The 1H NMR spectrum of EEQI-1 also showed the presence 
of characteristic hydroxyl protons at δ 8.85, δ 9.19 ppm and the acid group at δ 
12.15 ppm. The hydroxyl and carboxylic protons have broad signals in the upper 
spectra characteristic for 3, 4, 5-trihydroxybenzoic acid. Thus, according to the data 
and by comparison with the literature, the compound  was identified as Gallic acid 
(Figure 9). 
 
 
 
 
The qualitative analysis of the ethanol extract of seeds of Quercus infectoria 
was summarized in Table 4. Preliminary phytochemical screening revealed that 
EEQI showed the presence of carbohydrates, steroids, tannins & phenolic 
compounds, flavonoids, triterpenoids. The TLC study was carried out and the results 
were summarized in Table 5. From the TLC study of the EEQI, the presence of two 
spots were observed as maximum number of spots with Toluene: Ethyl acetate  
(8:  2)  using  iodine  vapours  as  detecting  agent.  The  Rf  values  of  the  spots  were 
calculated  and  found  to  be  0.62,  0.70  respectively.  The  results  of  column 
chromatography  of  the  ethanol  extract  of  seeds  of  Quercus  infectoria  was 
summarized in Table 6. Phytochemical analysis of the isolated compound EEQI-1 
has shown positive result for phenolic compounds. 
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Figure 9: Structure of Gallic acid 
 
 
 
PHARMACOLOGICAL SCREENING 
In vitro Anticancer Activity 
The anticancer activity of ethanol extract of Quercus infectoria was studied 
on the various cell line such as cervical cancer cell lines (HeLa), human liver cancer 
cell line) (Hep G2) and human breast cancer cell lines (MCF-7) using MTT assay 
method. The EEQI at doses of 62.5 µg/ml, 125 µg/ml,  250 µg/ml and 500 µg/ml 
produced a significant anticancer activity against HeLa, HepG2 and MCF-7 cancer 
cell lines. On comparison between the percentage cell inhibition of HeLa, Hep G2 
and MCF-7, the HepG2 showed higher inhibition and significant activity than the 
HeLa & MCF-7 which was mentioned in table 9 & figure 10.  
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Table 9.  % Cell Inhibition of EEQI in HeLa, Hep G2 and MCF-7 Cell Lines 
Concentration 
(µg/ml) 
% Cell Inhibition 
HeLa HepG2 MCF-7 
62.5 21.25 25.48 12.01 
125 36.02 43.10 15.55 
250 41.18 56.41 20.18 
500 54.41 63.18 36.01 
 
 
Figure 10. % Cell Inhibition of EEQI in HeLa, Hep G2 and MCF-7 Cell Lines 
 
Cancer is a disease caused by the abnormal proliferation and differentiation 
of cells and is governed by tumorigenic factors. Cancer is the second most common 
cause of human death worldwide. Currently, chemotherapy is still one of the best 
therapeutic methods to treat cancer. With wider application and further 
understanding, the side effects and acquired drug resistance of synthesized small 
molecule compounds have caused more and more concerns.54,55 Therefore, natural 
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and edible small molecules such as flavones, phenolic compounds which are thought 
to have remarkable physiological effects, low toxicity and non-mutagenic properties 
in the human body, have gained more and more interest in anti-cancer agent 
development.  
In the present study, HeLa, Hep G2 and MCF-7  cancer cell lines were used 
to find the cytotoxicity of the ethanol extract of Quercus infectoria due to their well 
defined characteristics in experimental conditions and their relevance as an in vitro 
system for screening purposes involving natural products and anti-mutagenic effects 
on this cells.56,57 The reduction of tetrazolium salts (MTT) is now recognized as a 
safe, accurate alternative to radiometric testing. Among the applications for the 
method are drug sensitivity, cytotoxicity, response to growth factors and 
activation.58, 59 HepG2 produced more significant in vitro anti-cancer activity than 
other two cell lines. Our findings shown that the antioxidant potentials like phenolic 
compounds, flavonoids, saponins present in extract might be responsible for the 
anticancer activities. Spectral datas of EEQI-1 (Gallic acid) also support anti-cancer 
activity of seeds of Quercus infectoria. 
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7. SUMMARY AND CONCLUSION 
Traditional Indian medicinal herbs have been used in the treatment of different 
diseases in the country for centuries. There have been claims that some traditional 
healers can successfully treat cancer using herbal drugs. The seeds of Quercus 
infectoria were selected and authenticated for the present study on the basis of 
ethanobotanical information.  
Literature survey revealed that not much work has done in this plant.  So I felt 
it worthwhile to validate scientifically, the folkclaim for its therapeutic activity.  The 
detailed preliminary phytochemical investigations proved its appropriate 
identification and rationalized its use as a drug of therapeutic importance. This plant 
have many phytoconstituents like flavonoids, phenolic compounds, saponins, tannins 
and so on. The phytoconstituents are found to possess pharmacological activities like 
antioxidant, antiulcer, antiinflammatory, antimicrobial, wound healing activities.  So 
it was planned to isolate active constituent  from ethanol extract of seeds of Quercus 
infectoria. The present study concluded that the phytoconstituent was isolated from 
the seeds of ethanol extract of Quercus infectoria and characterized systematically 
with IR, H1 NMR and mass spectroscopy.  The spectral datas of the isolated 
compound suggested that EEQI I showed the structural similarities with Gallic acid. 
Cancer is a complex multifactorial cell disease characterized by abnormal 
cellular proliferation. Cancer development is normally caused by oncogene, tumor 
suppressor gene, and microRNA gene alterations. It imposes a serious burden on the 
public health system, and its treatment and cure are scientifically challenging. Cancer 
is expected to claim nine million lives worldwide by 2015. Approximately 60% of 
anticancer agents are derived from medicinal plants and other natural resources; 
however, there are still a number of plants that have an anticancer potential but they 
have not yet been fully investigated. The MTT assay is used in screening the crude 
extracts as well as in the isolated compounds to assess the toxicity. It could also 
provide an indication of possible cytotoxic properties of the tested plant extracts. 
MTT assay is based on the reduction of MTT by mitochondrial dehydrogenase by 
purple formazan product. It is frequently used as an in vitro model system to measure 
cytotoxic effects of variety of toxic substances and plant extracts against cancer cell 
lines. Ethanol extract of seeds of Quercus infectoria was screened for in vitro 
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anticancer activitities in three different cell lines such as HeLa, Hep G2 and MCF-7 
by MTT assay method.   HepG2 produced more significant in vitro anticancer activity 
than other two cell lines. The present study concluded that the antioxidant potentials 
like phenolic compounds, tannins, flavonoids present in extract might be responsible 
for the anticancer activities. 
 In conclusion, it was observed that the plant seeds of Quercus infectoria 
contains a wide variety of secondary metabolites that hold strong antioxidant capacity 
based on the experiments performed which add scientific evidence to conduct further 
studies, investigate the lead compounds present in the plant, to evaluate its anticancer 
potential on in vivo animal models and put forward an attempt to carry out trials on 
human beings. 
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